| Financial Year |
March 31 2023 |
| Monetary Funds |
11,951,510,447.52 |
| Held-for-trading Financial Assets |
53,031,212.09 |
| Notes Receivable |
-- |
| Accounts Receivable |
3,106,798,064.41 |
| Advances to Suppliers |
856,847,860.53 |
| Other Receivables |
1,694,657,143.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
7,117,857,280.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,987,083,564.83 |
| Other Current Assets |
1,183,519,910.41 |
| Total Current Assets |
30,924,391,100.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,443,381,307.37 |
| Long-term Equity Investment |
4,287,054,545.56 |
| Investment Properties |
6,204,778,425.52 |
| Fixed Assetes |
33,329,526,740.35 |
| Under-construction Projects |
633,676,837.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
15,928,538.64 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,842,549,355.97 |
| R&D expenses |
-- |
| Goodwill |
26,946,905.38 |
| Long-Term Deferred and Prepaid Expenses |
43,302,562.31 |
| Deferred Income Tax Assets |
1,388,599,975.20 |
| Other Non-Current Assets |
965,190,876.15 |
| Sub-Total of Non-Current Assets |
51,147,501,270.38 |
| Total Assets |
82,071,892,371.00 |
| Short-Term Loans |
34,818,536,829.32 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,339,167,673.27 |
| Accounts Payable |
3,985,057,606.80 |
| Accounts Received In Advance |
16,197,519.31 |
| Employee Compensation Payable |
135,288,443.10 |
| Taxes Payable |
125,443,142.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,024,790,296.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,398,742,457.89 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
50,420,907,154.00 |
| Long-term Loans |
3,821,857,480.21 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,850,059,858.50 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,181,264.29 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,176,877,482.70 |
| Total Liabilities |
58,597,784,636.70 |
| Paid-In Capital(Or Share Stock) |
2,979,742,200.00 |
| Capital Surplus |
5,365,091,677.24 |
| Surplus Reserve |
1,212,009,109.97 |
| LESS:Treasury Stock |
128,780,100.00 |
| Undistributed Profits |
9,115,192,623.52 |
| Minority Stockholder's Interest |
4,651,333,955.17 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
18,822,773,779.13 |
| Owner's Equity（Stockholder's Equity） |
23,474,107,734.30 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
82,071,892,371.00 |
